GlassScriptPhysician profile
Hinrich Staecker
NPI 1518909050
$499,485.70
in general payments reported to CMS, 2019-2025
7 companies · $75.74 in 2025
The $75.74 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $18K · 2021: $117K · 2022: $70K · 2023: $99K · 2024: $147K · 2025: $75.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $195K · Travel and Lodging: $31K · Honoraria: $16K · Food and Beverage: $2,418 · Education: $643 · Charitable Contribution: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $195,351.35 |
| Travel and Lodging | $31,309.29 |
| Honoraria | $16,160.94 |
| Food and Beverage | $2,418.14 |
| Education | $643.00 |
| Charitable Contribution | $448.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $466,736.67 | 2019-2024 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Otonomy, INC. | $29,155.37 | 2020-2021 | |
| Horizon Therapeutics Plc | $3,000.00 | 2021 | |
| Astellas Pharma INC | $494.00 | 2024 | |
| Medtronic, INC. | $75.74 | 2025 | Midas Rex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.92 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hinrich Staecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.